This two-day symposium, chaired by Drs. Steve Hyman, Director of the Stanley Center for Psychiatric Research at the Broad Institute and Guoping Feng of McGovern Institute at MIT and Director of the Model Systems group of the Stanley Center, will bring together leading scientists working on the genetics and neurobiology of schizophrenia, bipolar disorder, autism and related neuropsychiatric disorders. The illnesses highlighted in this symposium cause lifelong disability to millions of persons – combined, more than 3% of the world population are affected by one of these severe disorders. This is an exciting moment in the science, as results emerging from large-scale genetics studies are revealing shared and unshared risk factors across multiple disorders, and more importantly are beginning to coalesce around molecular mechanisms underlying these diseases. In the coming years neuroscientists will be increasingly able to put the emerging genetics to work in the service of new understandings of pathophysiology, the development of biomarkers, and much needed new treatments. We hope, particularly, to attract graduate students and postdoctoral associates to this symposium in order to build this interdisciplinary field at a time of opportunity.
Day 1
| 7:45 | Registration and Breakfast |
| 8:45 - 9:00 | Welcome |
|
Session 1: Recent Advances in Genetics Chair: Aarno Palotie |
|
| 9:00 – 12:40 |
Population isolates in identifying low frequency variants in neurodevelopmental disorders Aarno Palotie |
|
CNVs conferring risk of schizophrenia affect cognition and brain structure in control carriers Hreinn Stefansson |
|
|
De novo mutations; convergence from CNVs and exome sequencing identifies synaptic pathology in schizophrenia and other neurodevelopmental disorders Michael O’Donovan |
|
|
When, where and what (cell types): moving from genomics to biology in autism spectrum disorders Matthew State |
|
|
|
Break |
|
Psychiatric Genomics Consortium quadruples schizophrenia GWAS sample size to 35,000 cases and 47,000 controls Stephan Ripke |
|
|
Design of PsychChip and analysis of rare coding variation in schizophrenia Benjamin Neale |
|
|
Complex variation and the genome’s missing pieces – what does whole genome sequencing have to teach us Steven McCarroll |
|
|
Late Breaking Talk (15 min) A statistical framework to interpret the role of de novo variation in psychiatric disease Kaitlin Samocha |
|
|
Genetics session wrap-up (10 min) Mark Daly |
|
| 12:40 – 1:40 | Lunch |
|
Session 2: Emerging Neurobiological Mechanisms Chair: Bernardo Sabatini |
|
| 1:40 – 4:55 |
Testing the possibility of synaptic dysfunction in schizophrenia Thomas Südhof |
|
Neural mechanisms underlying social reward Robert Malenka |
|
|
High throughput screens for synaptogenic factors Richard Huganir |
|
|
Genetic buffering and synaptic homeostasis in autism spectrum disorders Thomas Bourgeron |
|
| 3:20 – 3:40 | Break |
|
Circuit-specific synaptic dysfunction in autism Guoping Feng |
|
|
Immune mechanisms of synapse loss in health and disease Beth Stevens |
|
|
Hippocampal-prefrontal connectivity in a mouse model of the 22q11 microdeletion syndrome Joshua Gordon |
|
| 5:00 |
Poster session, reception and dinner buffet McGovern Institute Atrium Building 46 – MIT |
Day 2
|
|
Breakfast |
|
Session 3: Enabling Technologies Chair: Mriganka Sur |
|
|
|
Characterization of noncoding variants in schizophrenia Kai-How (Kyle) Farh |
|
Programming and reprogramming neuronal diversity in the cerebral cortex Paola Arlotta |
|
|
A stem cell approach for deciphering the results of genome-wide studies in psychiatric disease Kevin Eggan |
|
|
|
Break |
|
Genome Engineering: Technologies and Applications Feng Zhang |
|
|
Reading large-scale neural codes in freely behaving mice, in brain areas implicated in mental illness Mark Schnitzer |
|
|
Tools for Mapping Brain Computations Ed Boyden |
|
|
Optical deconstruction of fully-assembled biological systems Karl Deisseroth |
|
| 12:20 – 1:15 | Lunch |
|
Session 4: Translational Research and Target Identification Chair: Edward Scolnick |
|
| 1:15 – 2:55 |
Bridging genetics to drug discovery Dan Curtis |
|
A synaptic functional approach to CNS drug discovery David Gerber |
|
|
Quantitative proteomics to identify protein-small molecule interactions in primary neurons Monica Schenone |
|
|
Establishing an unbiased, scalable functional assay for neurons using multielectrode array recording Jen Pan |
|
| 2:55 – 3:15 | Break |
| 3:15 – 3:30 |
Development of D2R β-arrestin biased antagonists for the treatment of schizophrenia Michael Lewis |
| 3:30 – 3:45 |
Late Breaking Talk (15 min) Genetic modulation of neuronal competition homeostasis in the adult dentate gyrus to enhance hippocampal functions Kathleen McAvoy |
| 3:45 – 5:00 | Panel Discussion: Polices and Future Directions |
|
Steven Hyman Thomas Insel Thomas Lehner David Panchision Carlos Pato Ming Tsuang Patrick Sullivan |
|
| 5:00 |
Closing Remarks Steven Hyman |
